Italian guidelines for the diagnosis and treatment of Paget's disease of bone

被引:7
作者
Adami, S. [1 ]
Bartolozzi, P. [2 ]
Brandi, M. L. [3 ]
Falchetti, A. [3 ]
Filipponi, P. [4 ]
Gonnelli, S. [5 ]
Bianchi, G. [6 ]
Isaia, G. C. [7 ]
Nuti, R. [5 ]
机构
[1] Univ Verona, Reumatol, Verona, Italy
[2] Univ Verona, Clin Ortoped, Verona, Italy
[3] Univ Florence, Endocrinol, Florence, Italy
[4] Osped Umbertide, Med Interna, Umbertide, Italy
[5] Univ Siena, Med Interna, Siena, Italy
[6] Osped Arenzano, Reumatol, Arenzano, Italy
[7] Univ Turin, Med Interna, Turin, Italy
关键词
Paget's disease of bone; bisphosphonates;
D O I
10.4081/reumatismo.2007.153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paget's disease of bone is a chronic focal abnormality of bone turnover that remains totally asymptomatic over a very long period of time but that eventually ensue in bone pain and skeletal deformities. Although, in the last decade new insights have been obtained on its etiology, this remains largely obscure. Effective medical treatment (based on the use of bisphosphonates) has become available and the diagnostic procedures are now well defined. However, there remains considerable controversy regarding the hierarchy of diagnostic procedures and the medical treatment threshold. In the last few years different institution have published national guidelines, reflecting local national health systems and the available medical treatment. In this review, a working group derived from members of the SIOMMMS has examined the information available regarding the diagnosis and treatment of Paget's disease in order to develop guidelines to assist in the management of this condition. The first draft was then extensively reviewed by experts derived from the most representative scientific societies of rheumatology, internal medicine, and orthopaedic surgery. The document provides the most updated recommendations based primarily on the "evidence-based- medicine" but also on the Italian regulation for the diagnostic procedures and on the available medical treatments.
引用
收藏
页码:153 / 168
页数:16
相关论文
共 128 条
[1]  
Adami S, 2002, CLIN EXP RHEUMATOL, V20, P55
[2]   EFFECTS OF 2 ORAL DOSES OF ALENDRONATE IN THE TREATMENT OF PAGETS-DISEASE OF BONE [J].
ADAMI, S ;
MIAN, M ;
GATTI, P ;
ROSSINI, M ;
ZAMBERLAN, N ;
BERTOLDO, F ;
LOCASCIO, V .
BONE, 1994, 15 (04) :415-417
[3]   SEQUENTIAL TREATMENT OF PAGETS-DISEASE WITH HUMAN CALCITONIN AND DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) [J].
ADAMI, S ;
GUARRERA, G ;
SALVAGNO, G ;
SPIAZZI, G ;
MARINI, G ;
ROSINI, S ;
LOCASCIO, V .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1984, 5 (06) :265-267
[4]   THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION [J].
ADAMI, S ;
BHALLA, AK ;
DORIZZI, R ;
MONTESANTI, F ;
ROSINI, S ;
SALVAGNO, G ;
LOCASCIO, V .
CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) :326-331
[5]   TREATMENT OF PAGETS-DISEASE OF BONE WITH INTRAVENOUS 4-AMINO-1-HYDROXYBUTYLIDENE-1,1-BISPHOSPHONATE [J].
ADAMI, S ;
SALVAGNO, G ;
GUARRERA, G ;
MONTESANTI, F ;
GARAVELLI, S ;
ROSINI, S ;
LOCASCIO, V .
CALCIFIED TISSUE INTERNATIONAL, 1986, 39 (04) :226-229
[6]   Adverse effects of bisphosphonates - A comparative review [J].
Adami, S ;
Zamberlan, N .
DRUG SAFETY, 1996, 14 (03) :158-170
[7]   DURATION OF THE EFFECTS OF INTRAVENOUS ALENDRONATE IN POSTMENOPAUSAL WOMEN AND IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM AND PAGETS-DISEASE OF BONE [J].
ADAMI, S ;
ZAMBERLAN, N ;
MIAN, M ;
DORIZZI, R ;
ROSSINI, M ;
BRAGA, B ;
GATTI, D ;
BERTOLDO, F ;
LOCASCIO, V .
BONE AND MINERAL, 1994, 25 (02) :75-82
[8]   MINERALIZATION DEFECTS WITH PAMIDRONATE THERAPY FOR PAGETS-DISEASE [J].
ADAMSON, BB ;
GALLACHER, SJ ;
BYARS, J ;
RALSTON, SH ;
BOYLE, IT ;
BOYCE, BF .
LANCET, 1993, 342 (8885) :1459-1460
[9]  
AITKEN JM, 1973, LANCET, V1, P1177
[10]   LONG-TERM FOLLOW-UP OF THERAPY WITH INTERMITTENT ETIDRONATE DISODIUM IN PAGETS-DISEASE OF BONE [J].
ALTMAN, RD .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (05) :583-590